EP 4061378 A1 20220928 - A SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS DAPAGLIFLOZIN ISOLATED FROM A POLAR SOLVENT
Title (en)
A SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS DAPAGLIFLOZIN ISOLATED FROM A POLAR SOLVENT
Title (de)
FESTE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT AUS EINEM POLAREN LÖSUNGSMITTEL ISOLIERTEN AMORPHEN DAPAGLIFLOZIN
Title (fr)
COMPOSITION PHARMACEUTIQUE SOLIDE COMPRENANT DE LA DAPAGLIFLOZINE AMORPHE ISOLÉE À PARTIR D'UN SOLVANT POLAIRE
Publication
Application
Priority
- TR 201918102 A 20191120
- TR 2020050999 W 20201027
Abstract (en)
[origin: WO2021101482A1] The present invention relates to a solid pharmaceutical composition comprising amorphous dapagliflozin isolated from a polar solvent and at least one pharmaceutically acceptable excipients. Further the present invention provides a method for the preparation of said composition.
IPC 8 full level
A61K 31/70 (2006.01); A61K 31/7034 (2006.01); A61P 3/10 (2006.01); C07D 309/10 (2006.01)
CPC (source: EP)
A61K 9/2054 (2013.01); A61K 9/4866 (2013.01); A61K 31/70 (2013.01); A61P 3/10 (2017.12); C07D 309/10 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2021101482 A1 20210527; EP 4061378 A1 20220928; EP 4061378 A4 20231206; TR 201918102 A1 20210726
DOCDB simple family (application)
TR 2020050999 W 20201027; EP 20890661 A 20201027; TR 201918102 A 20191120